Parallax Volatility Advisers
ATYR

Parallax Volatility Advisers’s aTyr Pharma ATYR Stock Holding History

Parallax Volatility Advisers’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-93
Closed -$1K – 3771
2018
Q2 		$1K Hold
93
– – ﹤0.01% 2013
2018
Q1 		$3K Hold
93
– – ﹤0.01% 2007
2017
Q4 		$5K Hold
93
– – ﹤0.01% 3836
2017
Q3 		$7K Hold
93
– – ﹤0.01% 1784
2017
Q2 		$4K Hold
93
– – ﹤0.01% 2033
2017
Q1 		$5K Sell
93
-357
-79% -$16.3K ﹤0.01% 3311
2016
Q4 		$14K Buy
+450
New +$18.5K ﹤0.01% 2739

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GHCM
Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return
MCIM
Meadow Creek Investment Management Atlanta, Georgia $5.09B AUM 5.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Parallax Volatility Advisers's ATYR Position: Q3 2018 in Review

Parallax Volatility Advisers sold out of aTyr Pharma (ATYR) in Q3 2018, closing a stake of 93 shares — an estimated $1K sold.

Parallax Volatility Advisers first reported a position in ATYR in Q4 2016 and held it in 7 quarters. The position peaked at $14K in Q4 2016. 31 funds tracked by Wall St. Rank hold ATYR as of Q3 2018.

  • Parallax Volatility Advisers reported no remaining aTyr Pharma position as of Q3 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 93 aTyr Pharma shares in Q3 2018, an estimated $1K.
  • Parallax Volatility Advisers first reported a position in aTyr Pharma in Q4 2016 and held it in 7 quarters.
  • Parallax Volatility Advisers's aTyr Pharma position peaked at $14K in Q4 2016.
  • 31 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2018.

Based on Parallax Volatility Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.